UPDATE
: Monday, December 9, 2019
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
기사
(전체 1,559건)
제목보기
제목보기
제목+내용
기사보기
Ministry revokes Kolon Life Science’s innovative drug company status
The Ministry of Health a...
Lee Han-soo
|
2019-11-15 17:26
기사보기
AbbVie presents new data for ankylosing spondylitis treatment in US
AbbVie has presented pos...
Lee Han-soo
|
2019-11-15 11:40
기사보기
Merck Korea wins award for helping families with infertility problems
Merck Biopharma Korea sa...
Lee Han-soo
|
2019-11-14 18:05
기사보기
Prosecutors raid drugmakers, distributors for suspected bid-rigging
Prosecutors have begun i...
Jeong Sae-im
|
2019-11-14 15:27
기사보기
‘Novartis’ Kymriah takes one step closer to cancer cure’
Novartis has recently dr...
Lee Han-soo
|
2019-11-14 13:24
기사보기
iCure to apply for testing incrementally modified cancer drugs in US
iCure BNP said that it p...
Lee Han-soo
|
2019-11-13 17:35
기사보기
JW Pharmaceutical launches joint-stock company in Vietnam
JW Pharmaceutical said t...
Lee Han-soo
|
2019-11-13 16:52
기사보기
‘Generic drugs must indicate ingredient names on label’
“The results of ranitidi...
Kim Yun-mi
|
2019-11-13 15:51
기사보기
Daewoong releases trial results for autoimmune disease treatment in US
Daewoong Pharmaceutical ...
Lee Han-soo
|
2019-11-12 14:09
기사보기
Hanmi to get ₩11.6 billion in royalty if FDA approves Rolontis
Spectrum, Hanmi’s U.S. p...
Lee Han-soo
|
2019-11-11 18:02
기사보기
Genexine’s new immunotherapy shows stability even in high dose
GX-I7, a new immunothera...
Jeong Sae-im
|
2019-11-11 13:36
기사보기
Medpacto releases trial results at US conference
Medpacto, a subsidiary o...
Lee Han-soo
|
2019-11-11 13:27
-
1
2
3
4
5
6
7
8
9
10
다음
-
Back to Top